Pharmafile Logo
Pharmafocus logo
Advanced Search

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024
Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …

News

CMS commences formal review for Topical Oxygen Therapy coverage

November 11, 2024
Wound Healing, topical oxygen therapy, wound care

11 November 2024 AOTI, INC. (AIM: AOTI), a medical technology group focussed on the durable healing of wounds and prevention …

News
Press release

Johnson & Johnson receive MHRA approval for BALVERSA

November 8, 2024
Research and Development J&J Innovative Medicine, Oncology, Urology, bladder cancer

BALVERSA (erdafitinib) has been granted marketing approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment …

News

SolasCure partners with US Army for better wound care technology

November 6, 2024
Research and Development Dressings, hosiery & appliances, Solascare, US army, wound care, wound gel

SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …

News

NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink

November 5, 2024
Research and Development NorthWest Ehealth, clinical trials

The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …

News
Press release

FlyPharma Vienna 2024: An Event to Remember!

November 4, 2024
Corporate, FlyPharma 2024, Samedan, event

Samedan announces that their 2024 FlyPharma Conference, held in Office Park 4, Vienna AirportCity, Austria, has officially concluded! As a …

News
Press release

Valneva Scotland supports local cancer charity Team Jak Foundation 

October 31, 2024
Support Services Oncology, Scotland, Valneva Scotland, cancer charity, paediarics, vaccines

Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team Jak, helping towards the organisation’s …

News
Press release

University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma

October 30, 2024
Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors

Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …

News

Darrin Schellin appointed new CEO at Pharma Tech Industries

October 30, 2024
CEO, Pharma Tech Industries, manufacturing and packaging, pharmaceutical

Pharma Tech Industries, a pharmaceutical manufacturing and packaging solutions contractor for wellness products and medical devices, has announced the appointment …

Appointment

HIV vaccine candidate successfully optimised for industrial production

October 30, 2024
Research and Development HIV, HIV/AIDS, Naobios, Sumagen, Vaccine, agreement

Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise …

News
cancer_drip_2

Chiesi announces phase 3 results from enzyme-replacement study

October 29, 2024
Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases

Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …

News

From molecule to market and beyond: Uniphar announces extended global commercialization platform

October 25, 2024
CRO, UniPhar, cell and gene

22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 …

News
Press release

Shawn Cross appointed as chief financial officer for Pacira Biosciences

October 25, 2024
Research and Development Pacira Biosciences

Pacira Biosciences, spcecialist in non-opioid pain therapies, has appointed Shawn Cross as their chief financial officer. In this role, Mr …

Appointment

VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases

October 25, 2024
Nephrology, Rare Diseases, rare kidney disease, trial

SOBI and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit …

News

Stelis, Strides and Steriscience merge to form new CDMO

October 22, 2024
Research and Development CMDO, CPhI, Corporate, bangalore, merger

The CDMO launched earlier this year at the CPHI conference in Milan. The merger is comprised of Stelis Sciences, Strides …

News

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis

October 21, 2024
Research and Development CHMP, EMA, EU, Internal Medicine, gene

Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European Union (EU) by the European …

News

Eli Lilly appoints new chief AI officer

October 17, 2024
AI and ML, Corporate, Eli Lilly

Eli Lilly has announced the appointment of Thomas J Fuchs as its first chief artificial intelligence (AI) officer. Fuchs’ appointment …

Appointment

FlyPharma Europe, Vienna – 23-24 October 2024 conference

October 14, 2024
Conference, Corporate, flypharma, pharmaceutical

Samedan announces that on 23-24 October 2024, their FlyPharma Conference will make a welcome return to Office Park 4, Vienna …

News
Press release

Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study

October 3, 2024
Research and Development Ferring Pharmaceuticals, Gastrointestinal tract, ulcerative colitis

1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world …

News
Press release
handshake

Strategic alliance announced between Recipharm and Exela

October 1, 2024
Research and Development Corporate, Exela, Recipharm, US

Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The alliance between the two contract …

News
The Gateway to Local Adoption Series

Latest content

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026

Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women

January 13, 2026